Mathematically modelling the spread of hepatitis C in injecting drug users

被引:17
|
作者
Corson, S. [1 ]
Greenhalgh, D. [1 ]
Hutchinson, S. [1 ,2 ]
机构
[1] Univ Strathclyde, Dept Math & Stat, Glasgow G1 1HX, Lanark, Scotland
[2] Hlth Protect Scotland, Glasgow G3 7LN, Lanark, Scotland
基金
英国工程与自然科学研究理事会;
关键词
hepatitis C; injecting drug users; IDUs; HCV elimination; mathematical modelling; HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSMISSION; INFECTION; PREVALENCE; IMPACT; REINFECTION; PERSISTENCE; HIV/AIDS; GLASGOW; NEEDLES;
D O I
10.1093/imammb/dqr011
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mathematical modelling can provide valuable insights into the biological and epidemiological properties of infectious diseases as well as the potential impact of intervention strategies employed by health organizations worldwide. In this paper, we develop a deterministic, compartmental mathematical model to approximate the spread of the hepatitis C virus (HCV) in an injecting drug user (IDU) population. Using analytical techniques, we find that the model behaviour is determined by the basic reproductive number R-0, where R-0 = 1 is a critical threshold separating two different outcomes. If R-0 <= 1 and HCV is initially present in the population, we find that the system will reach a disease-free equilibrium where HCV has been eliminated in all IDUs and needles. If R-0 > 1, then there is a unique positive endemic equilibrium which we show is locally stable. We then use simulations to verify our analytical results and examine the effect of different parameter values and intervention measures on HCV prevalence estimates.
引用
收藏
页码:205 / 230
页数:26
相关论文
共 50 条
  • [41] Hepatitis B vaccination and injecting drug users
    Budd, J
    Robertson, R
    Elton, R
    BRITISH JOURNAL OF GENERAL PRACTICE, 2004, 54 (503): : 444 - 447
  • [42] Hepatitis A in injecting drug users: a national problem
    Gilroy, NM
    Tribe, IG
    Passaris, I
    Hall, R
    Beers, MY
    MEDICAL JOURNAL OF AUSTRALIA, 2000, 172 (03) : 142 - 143
  • [43] Acceptability of hepatitis C virus testing methods among injecting drug users
    White, Bethany
    Day, Carolyn
    Thein, Hla Hla
    Doab, Anna
    Bates, Anna
    Holden, Joanne
    van Beek, Ingrid
    Maher, Lisa
    DRUG AND ALCOHOL REVIEW, 2008, 27 (06) : 666 - 670
  • [44] Peer involvement and support is the key: hepatitis C treatment for injecting drug users
    Kelsall, J.
    Brogan, D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A335 - A335
  • [45] High Incidence of Hepatitis C Virus Reinfection in a Cohort of Injecting Drug Users
    Aitken, Campbell Kynoch
    Lewis, Jennifer
    Tracy, Samantha Lilly
    Spelman, Timothy
    Bowden, David Scott
    Bharadwaj, Mandvi
    Drummer, Heidi
    Hetlard, Margaret
    HEPATOLOGY, 2008, 48 (06) : 1746 - 1752
  • [46] Liver disease due to hepatitis C virus in injecting drug users.
    Ostapowicz, G
    Watson, KJR
    Desmond, PV
    GASTROENTEROLOGY, 1998, 114 (04) : A1318 - A1318
  • [47] The cost-effectiveness of testing for hepatitis C in former injecting drug users
    Castelnuovo, E.
    Thompson-Coon, J.
    Pitt, M.
    Cramp, M.
    Siebert, U.
    Price, A.
    Stein, K.
    HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (32) : 1 - +
  • [48] The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium
    Mathei, C.
    Van Dooren, S.
    Lemey, P.
    Van Damme, P.
    Buntinx, F.
    Vandamme, A. -M.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (06) : 399 - 408
  • [49] Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users
    Bowden, S
    McCaw, R
    White, PA
    Crofts, N
    Aitken, CK
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (03) : 322 - 324
  • [50] Cumulative incidence of hepatitis C seroconversion in a cohort of seronegative injecting drug users
    Brunton, C
    Kemp, R
    Raynel, P
    Harte, D
    NEW ZEALAND MEDICAL JOURNAL, 2000, 113 (1106) : 98 - 101